Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCSER2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | GSE1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | SETD2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | ZNF157 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | PEX11G | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | C1D | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | CARMIL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | PAIP2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | SENP1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |